Skip to main content

Table 1 The incidence number, ASIR, death number, ASDR and case fatality rate of 29 cancer types in 1990 and 2019

From: Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990–2019

Cancers

1990

2019

ASDR

Death number

ASIR

Incidence number

Case fatality rate(%)

ASDR

Death number

ASIR

Incidence number

Case fatality rate (%)

Esophageal cancer

8.18 (8.97–6.4)

319,332 (350,802–248,666)

8.06 (8.83–6.41)

319,969 (351,210–253,395)

101.5

6.11 (6.76–5.38)

498,067 (551,462–438,411)

6.51 (7.25–5.69)

534,563 (595,342–466,513)

93.9

Stomach cancer

20.48 (21.62–19.25)

788,317 (833,999–742,787)

22.44 (23.59–21.21)

883,396 (929,174–834,237)

91.3

11.88 (12.82–10.82)

957,185 (1,034,646–870,949)

15.59 (17.15–14.11)

1,269,806 (1,399,817–1,150,487)

76.2

Liver cancer

8.93 (9.9–8.09)

365,215 (405,774–329,967)

8.98 (9.97–8.1)

373,390 (415,748–335,890)

99.4

5.95 (6.44–5.44)

484,577 (525,798–444,091)

6.51 (7.16–5.95)

534,364 (588,639–486,550)

91.4

Larynx cancer

2.19 (2.29–2.08)

87,459 (91,551–83,182)

3.06 (3.17–2.93)

124,643 (129,440–119,744)

71.6

1.49 (1.61–1.39)

123,356 (132,798–114,941)

2.51 (2.69–2.32)

209,149 (224,620–193,876)

59.4

Tracheal, bronchus, and lung cancer

27.3 (28.59–26.03)

1,065,139 (1,117,181–1,019,217)

28.39 (29.67–27.18)

1,124,006 (1,176,491–1,077,618)

96.2

25.18 (27.01–23.16)

2,042,640 (2,193,269–1,879,241)

27.66 (29.99–25.28)

2,259,998 (2,451,832–2,067,316)

91.0

Breast cancer

9.8 (10.21–9.3)

380,905 (396,714–364,815)

21.44 (22.1–20.65)

876,993 (903,815–849,689)

45.7

8.62 (9.25–7.95)

700,660 (751,555–647,384)

24.17 (26.24–22.11)

2,002,354 (2,172,540–1,832,150)

35.7

Cervical cancer

4.46 (5.31–4)

184,527 (218,942–164,836)

7.64 (9.01–6.87)

335,642 (393,893–300,354)

58.4

3.4 (3.81–2.9)

280,479 (313,930–238,864)

6.81 (7.66–5.81)

565,541 (636,435–481,524)

49.9

Uterine cancer

1.48 (1.58–1.35)

56,130 (60,199–51,104)

4.61 (4.82–4.31)

187,191 (196,030–174,631)

32.1

1.13 (1.25–1.01)

91,641 (101,502–82,389)

5.21 (5.75–4.75)

435,041 (479,729–397,021)

21.7

Prostate cancer

6.98 (8.1–5.69)

232,999 (268,882–191,398)

14.25 (16.62–11.18)

524,110 (613,006–409,133)

49.0

6.32 (7.71–5.42)

486,836 (593,689–420,498)

17.39 (22.5–15.12)

1,410,452 (1,825,766–1,227,900)

36.3

Colon and rectum cancer

14.31 (14.88–13.52)

518,126 (537,877–493,682)

22.25 (22.97–21.29)

842,098 (868,574–810,408)

64.3

13.69 (14.51–12.6)

1,085,797 (1,149,679–1,002,795)

26.71 (28.89–24.58)

2,166,168 (2,342,842–1,996,298)

51.3

Lip and oral cavity cancer

2.44 (2.6–2.28)

96,628 (103,050–90,592)

4.28 (4.51–4.07)

175,626 (184,913–167,516)

57.0

2.44 (2.66–2.22)

199,398 (218,059–181,651)

4.52 (4.89–4.13)

373,098 (403,866–340,884)

54.0

Nasopharynx cancer

1.26 (1.36–1.15)

53,459 (57,906–48,875)

1.55 (1.67–1.42)

67,518 (72,995–61,729)

81.3

0.86 (0.93–0.79)

71,610 (77,625–65,442)

2.12 (2.4–1.87)

176,502 (199,917–156,046)

40.6

Other pharynx cancer

1.25 (1.37–1.17)

51,460 (56,457–47,974)

1.6 (1.72–1.5)

66,531 (71,527–62,626)

78.1

1.37 (1.51–1.24)

114,207 (126,039–103,154)

1.99 (2.15–1.83)

166,901 (180,359–152,960)

68.8

Gallbladder and biliary tract cancer

2.6 (2.93–2.3)

94,855 (107,240–85,139)

2.91 (3.22–2.58)

107,787 (119,860–96,900)

89.3

2.17 (2.38–1.81)

172,441 (188,615–144,899)

2.49 (2.75–2.09)

199,211 (219,615–166,769)

87.1

Pancreatic cancer

5.34 (5.52–5.07)

198,051 (204,763–189,329)

5.22 (5.4–4.97)

197,348 (203,971–188,604)

102.3

6.62 (7.06–6.11)

531,107 (566,537–491,948)

6.57 (7.09–6)

530,297 (573,635–486,175)

100.8

Malignant skin melanoma

0.85 (1.1–0.72)

33,083 (43,094–27,827)

2.56 (3.25–2.05)

107,380 (134,056–85,128)

33.2

0.79 (0.89–0.58)

62,844 (71,001–46,317)

3.56 (4.19–2.63)

289,953 (341,965–214,481)

22.2

Non-melanoma skin cancer

0.69 (0.73–0.63)

23,222 (24,436–21,441)

54.08 (62.08–46.97)

1,951,299 (2,237,075–1,692,794)

1.3

0.73 (0.78–0.65)

56,054 (59,792–50,415)

79.1 (86.63–72.29)

6,353,687 (6,952,145–5,805,441)

0.9

Ovarian cancer

2.5 (2.8–2.32)

97,363 (109,761–89,703)

3.42 (3.84–3.17)

141,706 (160,779–130,541)

73.1

2.43 (2.66–2.15)

198,412 (217,665–175,357)

3.58 (4–3.17)

294,422 (329,727–260,649)

67.9

Testicular cancer

0.15 (0.16–0.14)

7224 (7906–6792)

0.96 (1.12–0.78)

51,893 (61,388–41,490)

15.6

0.14 (0.15–0.13)

10,842 (11,902–9961)

1.4 (1.67–1.18)

109,313 (129,454–93,372)

10.0

Kidney cancer

1.86 (1.93–1.77)

72,100 (74,674–68,876)

3.53 (3.63–3.4)

145,906 (150,333–140,803)

52.7

2.08 (2.2–1.93)

166,438 (176,302–155,461)

4.55 (4.93–4.22)

371,747 (402,350–344,594)

45.7

Bladder cancer

3.49 (3.66–3.27)

121,500 (127,171–114,751)

6.27 (6.5–5.98)

234,754 (243,075–225,464)

55.7

2.94 (3.13–2.7)

228,735 (243,193–210,743)

6.52 (7.09–5.93)

524,305 (569,434–475,952)

45.1

Brain and central nervous system cancer

3.08 (4.01–2.71)

139,632 (182,291–119,905)

3.82 (5–3.34)

179,051 (237,072–152,530)

80.6

3.05 (3.36–2.29)

246,253 (270,930–185,642)

4.34 (4.86–3.27)

347,992 (388,896–262,084)

70.3

Thyroid cancer

0.6 (0.66–0.56)

22,966 (25,228–21,554)

2.01 (2.12–1.9)

87,583 (92,717–82,236)

29.9

0.57 (0.61–0.51)

45,576 (48,775–41,290)

2.83 (3.06–2.56)

233,847 (252,807–211,637)

20.1

Mesothelioma

0.4 (0.44–0.36)

15,385 (17,017–13,815)

0.49 (0.54–0.44)

19,072 (21,157–17,055)

81.6

0.36 (0.39–0.33)

29,251 (31,006–26,668)

0.43 (0.47–0.38)

34,511 (37,771–31,199)

83.7

Hodgkin lymphoma

0.61 (0.66–0.48)

27,602 (30,235–21,663)

1.26 (1.35–1.02)

59,688 (64,237–48,254)

48.4

0.34 (0.4–0.29)

27,552 (31,813–23,685)

1.1 (1.27–0.98)

87,509 (101,425–77,941)

30.9

Non-Hodgkin lymphoma

3.15 (3.29–3)

126,082 (131,976–119,768)

4.65 (4.93–4.37)

190,725 (203,617–179,033)

67.7

3.19 (3.39–2.98)

254,614 (270,353–237,714)

5.73 (6.25–5.21)

457,077 (498,785–416,894)

55.7

Multiple myeloma

1.4 (1.58–1.28)

51,862 (58,980–47,710)

1.73 (1.93–1.59)

65,941 (74,059–60,780)

80.9

1.42 (1.52–1.24)

113,474 (121,735–99,527)

1.92 (2.12–1.68)

155,688 (172,577–136,585)

74.0

Leukemia

5.82 (6.44–5.25)

263,263 (298,696–233,664)

9.6 (11.02–8.14)

474,924 (560,550–388,559)

60.6

4.26 (4.58–3.91)

334,592 (360,214–306,818)

8.22 (8.94–7.5)

643,579 (699,729–586,980)

51.8

Other malignant neoplasms

5.64 (6.02–5.08)

238,783 (255,399–215,826)

8.49 (9.05–7.73)

379,732 (407,125–347,417)

66.4

5.14 (5.58–4.48)

408,167 (443,578–355,053)

10.45 (11.38–9.33)

831,446 (905,631–741,237)

49.2